BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
iShares MSCI ACWI ETF
ACWI
|
+$981M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$944M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
+$873M |
| 5 |
Microsoft
MSFT
|
+$816M |
Top Sells
| 1 |
Home Depot
HD
|
+$243M |
| 2 |
Fiserv
FI
|
+$152M |
| 3 |
American Tower
AMT
|
+$144M |
| 4 |
Tesla
TSLA
|
+$138M |
| 5 |
Uber
UBER
|
+$112M |
Sector Composition
| 1 | Technology | 19.65% |
| 2 | Financials | 12.31% |
| 3 | Consumer Discretionary | 8.67% |
| 4 | Healthcare | 6.81% |
| 5 | Communication Services | 6.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGRX
2701
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $93.5K | ﹤0.01% |
2,240
+388
| +21% | +$16.2K |
|
|
AGS
2702
DELISTED
PlayAGS
AGS
| $93.4K | ﹤0.01% |
11,557
+2,515
| +28% | +$20.3K |
|
2703
First Bank
FRBA
$415M
| $93.1K | ﹤0.01% |
7,651
+3,523
| +85% | +$42.9K |
|
2704
Karyopharm Therapeutics
KPTI
$53.8M
| $92.8K | ﹤0.01% |
588
-5,764
| -91% | -$910K |
|
|
HMTV
2705
DELISTED
Hemisphere Media Group, Inc.
HMTV
| $92.7K | ﹤0.01% |
7,957
+3,810
| +92% | +$44.4K |
|
2706
Duluth Holdings
DLTH
$132M
| $92.5K | ﹤0.01% |
5,459
+1,450
| +36% | +$24.6K |
|
|
SRT
2707
DELISTED
Startek Inc.
SRT
| $92.4K | ﹤0.01% |
11,619
+3,377
| +41% | +$26.8K |
|
2708
Gold Resource Corp
GORO
$114M
| $92.2K | ﹤0.01% |
34,931
+17,934
| +106% | +$47.3K |
|
2709
Limoneira
LMNR
$269M
| $91.1K | ﹤0.01% |
5,204
+1,444
| +38% | +$25.3K |
|
2710
Shore Bancshares
SHBI
$567M
| $90.5K | ﹤0.01% |
5,317
+1,972
| +59% | +$33.6K |
|
|
CWBC
2711
Community West Bancshares
CWBC
$402M
| $90.3K | ﹤0.01% |
4,906
+1,797
| +58% | +$33.1K |
|
|
TCFC
2712
DELISTED
The Community Financial Corporation Common Stock
TCFC
| $89.7K | ﹤0.01% |
2,619
+1,445
| +123% | +$49.5K |
|
2713
ING
ING
$72.9B
| $89.6K | ﹤0.01% |
7,327
+7,282
| +16,182% | +$89.1K |
|
|
XONE
2714
DELISTED
The ExOne Company
XONE
| $89.6K | ﹤0.01% |
2,857
+615
| +27% | +$19.3K |
|
|
ESTE
2715
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $89.5K | ﹤0.01% |
12,524
+4,977
| +66% | +$35.6K |
|
|
ATRS
2716
DELISTED
Antares Pharma, Inc.
ATRS
| $89.1K | ﹤0.01% |
21,683
-10,520
| -33% | -$43.2K |
|
|
LGTY
2717
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $88.6K | ﹤0.01% |
4,282
-28,231
| -87% | -$584K |
|
|
IHC
2718
DELISTED
Independence Holding Company
IHC
| $88.6K | ﹤0.01% |
2,224
+983
| +79% | +$39.2K |
|
2719
Western New England Bancorp
WNEB
$248M
| $88.6K | ﹤0.01% |
10,508
+4,533
| +76% | +$38.2K |
|
2720
Sanofi
SNY
$115B
| $88.4K | ﹤0.01% |
1,788
-337
| -16% | -$16.7K |
|
2721
Northeast Bank
NBN
$941M
| $88.2K | ﹤0.01% |
3,343
+1,895
| +131% | +$50K |
|
2722
Investors Title Co
ITIC
$467M
| $88.1K | ﹤0.01% |
531
+232
| +78% | +$38.5K |
|
2723
First Trust Dow Jones Internet Index Fund ETF
FDN
$7.92B
| $87.7K | ﹤0.01% |
402
-126
| -24% | -$27.5K |
|
|
AERI
2724
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $87K | ﹤0.01% |
4,870
-2,206
| -31% | -$39.4K |
|
2725
Barclays
BCS
$72.8B
| $86.8K | ﹤0.01% |
8,486
-25,281
| -75% | -$259K |
|